Developing science,
delivering therapies


Our company

We are pioneers in harnessing bacteria as a revolutionary new class of medicines – called live biotherapeutics.

Our approach

Developing science

From asthma to cancer, we conduct world-leading research to identify live biotherapeutics with drug-like functionality to treat a range of diseases.

What we do

Delivering therapies

We are uniquely positioned to rapidly translate our research into regulated, safe and efficacious therapies for patients.

Find out more


4D pharma makes strategic appointment of independent Non-Executive Director in response to new clinical success and next stages of global development
4D pharma's Research Director, Dr Imke Mulder, and members of her Research team provide an overview of the MicroRx® platfrom. The presentation is followed by an insightful Q&A session with invited analysts
4D pharma announces complete 6-month clinical benefit data from Part A of its ongoing trial of Live Biotherapeutic MRx0518 in combination with Keytruda